AEMD vs AMIX

Aethlon Medical, Inc. vs Autonomix Medical, Inc. — Valuation Comparison 2026

AEMD

Medical Devices
Aethlon Medical, Inc.
Quality
4.6
out of 10
Value Trap
18
SAFE
Price
$2.21
Last close
Models
6/13
Active
VS

AMIX

Medical Devices
Autonomix Medical, Inc.
Quality
4.3
out of 10
Value Trap
Price
$0.40
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType AEMD Fair ValueAEMD Upside AMIX Fair ValueAMIX Upside
Bayesian DCF Intrinsic $2.86 +29.3% $0.58 +46.0%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.40 -82.8% $0.07 -81.7%
Dynamic NAV Asset-Based $1.10 +173.8%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for AEMD vs AMIX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AEMD vs AMIX — Which Stock Is More Undervalued?

AEMD scores higher with a 4.6/10 quality rating vs AMIX's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aethlon Medical, Inc. (AEMD) and Autonomix Medical, Inc. (AMIX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AEMD currently trades at $2.21 with a QOC of 4.6/10, while AMIX trades at $0.40 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).